Machiels, J. H., Licitra, L. F., Haddad, R. I., Tahara, M., & Cohen, E. E. (2014). Rationale and design of LUX-Head & Neck 1: A randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy. BioMed Central.
Chicago Stili AlıntıMachiels, Jean-Pascal H., Lisa F. Licitra, Robert I. Haddad, Makoto Tahara, ve Ezra EW Cohen. Rationale and Design of LUX-Head & Neck 1: A Randomised, Phase III Trial of Afatinib Versus Methotrexate in Patients With Recurrent And/or Metastatic Head and Neck Squamous Cell Carcinoma Who Progressed After Platinum-based Therapy. BioMed Central, 2014.
MLA AlıntıMachiels, Jean-Pascal H., et al. Rationale and Design of LUX-Head & Neck 1: A Randomised, Phase III Trial of Afatinib Versus Methotrexate in Patients With Recurrent And/or Metastatic Head and Neck Squamous Cell Carcinoma Who Progressed After Platinum-based Therapy. BioMed Central, 2014.